Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. [electronic resource]
Producer: 20170828Description: e0171356 p. digitalISSN:- 1932-6203
- Apoptosis -- drug effects
- Blotting, Western
- Breast Neoplasms -- metabolism
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Computational Biology
- Drug Resistance, Neoplasm -- genetics
- Female
- Humans
- Lapatinib
- Proto-Oncogene Mas
- Proto-Oncogene Proteins c-yes -- genetics
- Quinazolines -- pharmacology
- RNA, Small Interfering -- genetics
- Receptor, ErbB-2 -- metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Signal Transduction -- drug effects
- Trastuzumab -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.